CG Oncology, Inc.
CGON
$19.28
$1.659.36%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.14M | 684.00K | 650.00K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.14M | 684.00K | 650.00K | -- | -- |
| Cost of Revenue | 82.10M | 71.64M | 63.76M | -- | -- |
| Gross Profit | -80.96M | -70.96M | -63.11M | -- | -- |
| SG&A Expenses | 33.70M | 25.01M | 18.62M | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 115.81M | 96.66M | 82.37M | -- | -- |
| Operating Income | -114.67M | -95.97M | -81.72M | -- | -- |
| Income Before Tax | -88.04M | -72.79M | -64.16M | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -88.04 | -72.79 | -64.16 | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -88.04M | -72.79M | -64.16M | -- | -- |
| EBIT | -114.67M | -95.97M | -81.72M | -- | -- |
| EBITDA | -114.63M | -95.94M | -81.70M | -- | -- |
| EPS Basic | -1.41 | -5.30 | -8.99 | -- | -- |
| Normalized Basic EPS | -0.88 | -2.60 | -4.08 | -- | -- |
| EPS Diluted | -1.41 | -5.30 | -8.99 | -- | -- |
| Normalized Diluted EPS | -0.88 | -2.60 | -4.08 | -- | -- |
| Average Basic Shares Outstanding | 249.91M | 186.02M | 123.26M | -- | -- |
| Average Diluted Shares Outstanding | 249.91M | 186.02M | 123.26M | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
